What is known about the immune response induced by Plasmodium vivax malaria vaccine candidates?

Malaria caused by Plasmodium vivax continues being one of the most important infectious diseases around the world; P. vivax is the second most prevalent species and has the greatest geographic distribution. Developing an effective antimalarial vaccine is considered a relevant control strategy in the...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2017

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/24090

Acceso en línea:

https://doi.org/10.3389/fimmu.2017.00126
https://repository.urosario.edu.co/handle/10336/24090

Palabra clave:

Apical membrane antigen 1
Chemokine
Circumsporozoite protein
Duffy binding protein
Malaria vaccine
Merozoite surface protein 3
Merozoite surface protein 9
Protozoal protein
Recombinant protein
Synthetic peptide
Transcription factor
Unclassified drug
Adaptive immunity
Antigen binding
B lymphocyte
Cell invasion
Disease severity
Geographic distribution
Helper cell
Host cell
Human
Immune response
Immunological tolerance
Inflammation
Innate immunity
Macrophage activation
Minor histocompatibility complex
Natural killer cell
Neuromuscular blocking
Nonhuman
Pathogenesis
Phagolysosome
Plasmodium vivax malaria
Review
Serology
Sporozoite
T lymphocyte activation
Vaccine immunogenicity
Antigenicity
Immune response
Immunogenicity
Malaria
Plasmodium vivax

Rights

License

Abierto (Texto Completo)